We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Danimer Scientific (DNMR) Expands Partnership With CPChem
Read MoreHide Full Article
Danimer Scientific, Inc. (DNMR - Free Report) has announced that it is extending its partnership with Chevron Phillips Chemical ("CPChem") to explore several high-volume polymer applications using Rinnovo materials.
CPChem provides polymers and petrochemical products employed in manufacturing processes around the world. It is owned by Chevron Corporation (CVX - Free Report) and Phillips 66 (PSX - Free Report) . It was established in July 2000 by merging the chemicals operations of Chevron and Phillips.
Danimer Scientific and CPChem previously announced a collaboration in which Danimer Scientific was evaluating the use of CPChem's loop slurry reactor design to establish a continuous reactor system in the Rinnovo production process. This time, the companies intend to explore the development and commercialization of Rinnovo-based cast extrusion films, blown extrusion films, injection molded parts, and rotational molded parts.
Rinnovo is a polyhydroxyalkanoate synthesized from lactones utilizing Danimer Scientific's unique Novo22 catalyst technology. It can be used in the production of biodegradable alternatives to standard plastics.
Opened in 1950, CPChem’s Research and Technology lab in Bartlesville contains first-class research equipment, allowing for the rapid testing of products across various processing conditions. This collaboration will accelerate the adoption of Rinnovo materials in high-volume applications, lowering the cost to serve the key markets.
Danimer Scientific is committed to developing more sustainable, natural methods of producing plastic products. This collaboration is in line with that commitment.
The company reported an adjusted loss of 38 cents per share in the second quarter of 2023, wider than the Zacks Consensus Estimate of a loss of 36 cents. It reported an adjusted loss of 30 cents per share in the prior-year quarter. Danimer Scientific posted revenues of $12.87 million for the quarter ended June 2023.
Price Performance
Shares of Danimer Scientific have lost 47.9% in the past year against the industry's growth of 16%.
Image Source: Zacks Investment Research
Zacks Rank & Another Stock to Consider
Danimer Scientific currently carries a Zacks Rank #2 (Buy).
Caterpillar has an average trailing four-quarter earnings surprise of 18.5%. The Zacks Consensus Estimate for CAT’s 2023 earnings is pegged at $19.81 per share. The consensus estimate for 2023 earnings has moved north by 11.4% in the past 60 days. Its shares gained 51.6% in the last year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Danimer Scientific (DNMR) Expands Partnership With CPChem
Danimer Scientific, Inc. (DNMR - Free Report) has announced that it is extending its partnership with Chevron Phillips Chemical ("CPChem") to explore several high-volume polymer applications using Rinnovo materials.
CPChem provides polymers and petrochemical products employed in manufacturing processes around the world. It is owned by Chevron Corporation (CVX - Free Report) and Phillips 66 (PSX - Free Report) . It was established in July 2000 by merging the chemicals operations of Chevron and Phillips.
Danimer Scientific and CPChem previously announced a collaboration in which Danimer Scientific was evaluating the use of CPChem's loop slurry reactor design to establish a continuous reactor system in the Rinnovo production process. This time, the companies intend to explore the development and commercialization of Rinnovo-based cast extrusion films, blown extrusion films, injection molded parts, and rotational molded parts.
Rinnovo is a polyhydroxyalkanoate synthesized from lactones utilizing Danimer Scientific's unique Novo22 catalyst technology. It can be used in the production of biodegradable alternatives to standard plastics.
Opened in 1950, CPChem’s Research and Technology lab in Bartlesville contains first-class research equipment, allowing for the rapid testing of products across various processing conditions. This collaboration will accelerate the adoption of Rinnovo materials in high-volume applications, lowering the cost to serve the key markets.
Danimer Scientific is committed to developing more sustainable, natural methods of producing plastic products. This collaboration is in line with that commitment.
The company reported an adjusted loss of 38 cents per share in the second quarter of 2023, wider than the Zacks Consensus Estimate of a loss of 36 cents. It reported an adjusted loss of 30 cents per share in the prior-year quarter. Danimer Scientific posted revenues of $12.87 million for the quarter ended June 2023.
Price Performance
Shares of Danimer Scientific have lost 47.9% in the past year against the industry's growth of 16%.
Image Source: Zacks Investment Research
Zacks Rank & Another Stock to Consider
Danimer Scientific currently carries a Zacks Rank #2 (Buy).
Another top-ranked stock from the Industrial Products sector is Caterpillar Inc. (CAT - Free Report) . CAT sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
Caterpillar has an average trailing four-quarter earnings surprise of 18.5%. The Zacks Consensus Estimate for CAT’s 2023 earnings is pegged at $19.81 per share. The consensus estimate for 2023 earnings has moved north by 11.4% in the past 60 days. Its shares gained 51.6% in the last year.